Navigation Links
Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels
Date:2/9/2011

NEWTON, Mass., Feb. 9, 2011 /PRNewswire/ -- Rcadia Medical Imaging announced today that it has received FDA 510(k) marketing clearance for an enhanced version of its COR Analyzer® System to assess coronary branch vessels in addition to main coronary arteries in patients with suspected coronary artery disease (CAD). The clearance is the third for the COR Analyzer System, a unique clinical decision support tool that automatically detects significant (50 percent and over) stenotic lesions in coronary arteries from Coronary CT Angiography (cCTA) studies.

"The enhanced version expands the benefits of the COR Analyzer System as a powerful complement to cCTA in evaluating suspected CAD patients," said Shai Levanon, President and CEO of Rcadia. "By providing rapid detection of stenotic lesions our system enables expanded use of cCTA to enhance patient care and reduce unnecessary costs."

The FDA clearance follows the recent publication of the first clinical study evaluating the COR Analyzer's enhanced version. The study, published (online) in Academic Radiology in January 2011 by researchers at Thomas Jefferson University, demonstrated that the "COR Analyzer provides a high negative predictive value for the absence of coronary disease in branch vessels as well as the major coronary arteries."  

The retrospective study, conducted by Ethan Halpern, MD, and David Halpern, compared 207 cases evaluated by the COR Analyzer System with expert interpretation. The final clinical interpretation identified 48 patients with significant (over 50 percent) stenosis. The COR Analyzer System demonstrated a sensitivity of 92 percent and a negative predictive value of 97 percent. In the study, the system's specificity was 70 percent and the positive predictive value was 48 percent.

The investigators noted that the "high negative predictive value will be most useful in a population with a low prevalence of coronary disease - such as the emergency room chest pain population - where the COR Analyzer might be used to facilitate the rapid discharge of a majority of patients who have normal coronary CTA studies during all hours of the day or night."

About Rcadia Medical Imaging

Rcadia Medical Imaging Ltd. develops and markets proprietary computerized systems that automatically detect clinical abnormalities in digital medical images, particularly for patient triage in emergency, life threatening conditions. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT angiography to enable the practical application of cCTA in detecting significant coronary artery disease. The COR Analyzer improves the utility of Coronary CTA studies in the emergency department to triage chest pain patients and optimizes work flow in cardiology and radiology departments. Learn more at www.rcadia.com.


'/>"/>
SOURCE Rcadia Medical Imaging
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Rcadia Medical Imaging Wins 2009 AuntMinnie.com Best New Radiology Vendor Award
4. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
5. Arcadia Resources to Present at Lazard Healthcare Conference in New York
6. Arcadia Resources Names Stephen Goldsmith to Board of Directors
7. Rcadia Medical Imaging’s COR Analyzer(R) System Receives CE Mark
8. Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
9. Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting
10. Arcadian Healths Chief Information Officer to Address Role of CIOs from a Healthcare Perspective at the CIO Executive Leadership Roundtable in Santa Monica
11. Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... 10, 2017 The Institute for In Vitro ... the recipient of a VITROCELL® inhalation exposure system thanks ... Consortium. The device, which is designed to replace animals ... lung cells to airborne test materials in an environment ... VITROCELL® system for testing combustible tobacco products, as well ...
(Date:7/5/2017)... -- Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials proves ... to progress molecular radiotherapy imaging. In molecular radiotherapy ... accurately quantify the radiation absorbed by those patients undergoing treatment. ... this radiotherapy treatment has been available — that is, until ... ...
Breaking Medicine Technology:
(Date:7/20/2017)... , ... July 20, 2017 , ... Team Type 1 ... to medicine for everyone affected by diabetes, is teaming up with a Microsoft Corp. ... event kicks off on July 24th. , “Team Type 1’s mission overlaps seamlessly ...
(Date:7/20/2017)... ... , ... The Dermatology Clinic announced today the addition of Dr. Scott W. ... LSU, graduating summa cum laude. He attended Emory University School of Medicine in Atlanta ... Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship to ...
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch to an alternate ... - adjustment (COLA) is a bad deal for older and disabled Americans, says ... would grow even more slowly than the conventional one that is currently used to ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), a leading health ... business unit of Constellation Inc., a move that will help the company better serve ... St. Louis, the acquisition is expected to help MTS expand its presence ...
(Date:7/20/2017)... ... 2017 , ... “Fidget”: a fun-filled, action-packed memoir of adventures. “Fidget” is the ... drama teacher who was a summa cum laude graduate of Gardner Webb University. She ... award. After her retirement from public school, Lynn continued to pursue her love for ...
Breaking Medicine News(10 mins):